Share chart Anebulo Pharmaceuticals, Inc.
Extended chart
Simple chart
About Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. The company was incorporated in 2020 and is based in Lakeway, Texas.| IPO date | 2021-05-07 |
|---|---|
| ISIN | US0345691036 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.anebulo.com |
| Цена ао | 1.23 |
| Change price per day: | -3.33% (1.2) |
|---|---|
| Change price per week: | -7.94% (1.26) |
| Change price per month: | -24.68% (1.54) |
| Change price per 3 month: | -19.44% (1.44) |
| Change price per half year: | -35.91% (1.81) |
| Change price per year: | -57.82% (2.75) |
| Change price per 3 year: | -83.99% (7.247) |
| Change price per 5 year: | 0% (1.16) |
| Change price per 10 year: | 0% (1.16) |
| Change price per year to date: | +17.17% (0.99) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| 22NW, LP | 5366290 | 20.93 |
| Nantahala Capital Management, LLC | 1022146 | 3.99 |
| LVW Advisors, LLC | 643039 | 2.51 |
| Morgan Stanley | 399219 | 1.56 |
| Ikarian Capital, LLC | 157862 | 0.62 |
| Vanguard Group Inc | 153003 | 0.6 |
| BOOTHBAY FUND MANAGEMENT, LLC | 18978 | 0.07 |
| Landscape Capital Management LLC | 15000 | 0.06 |
| Tower Research Capital LLC (TRC) | 9102 | 0.04 |
| Blackrock Inc. | 4145 | 0.02 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| iShares Micro-Cap ETF | 0.0012 | 17.09 | 1.54048 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Dr. Joseph F. Lawler M.D., Ph.D. | Founder & Chairman | 11k | 1972 (53 years) |
| Dr. Kenneth C. Cundy Ph.D. | Chief Scientific Officer | 425.15k | 1959 (66 years) |
| Mr. Richard Anthony Cunningham | CEO & Director | N/A | 1971 (54 years) |
| Mr. Daniel V. George | Principal Accounting Officer, Acting CFO & Secretary | N/A | 1970 (55 years) |
Address: United States, Lakeway. TX, 1017 Ranch Road 620 South - open in Google maps, open in Yandex maps
Website: https://www.anebulo.com
Website: https://www.anebulo.com
